Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Glimpses of how the brain transforms sound

  • How to stop a stroke in its tracks

  • Discovery may open door for treating fragile X carriers

  • Fat tissue controls brain's response to food scarcity, helping regulate optimal amount of body fat for brain function

  • New light shed on brain's source of power

  • Long-term exposure to air pollution may pose risk to brain structure, cognitive functions

  • Extra sleep fixes memory problems in flies with Alzheimer's-like condition

  • In search of tinnitus, that phantom ringing in the ears

  • Nanoparticle drug reverses Parkinson's-like symptoms in rats

  • Researchers see promise in treatment to reduce dementia after TBI

  •